Literature DB >> 15051860

Manufacture and use of dairy protein fractions.

Mark R Etzel1.   

Abstract

Fractionation of the mixture of proteins found in milk and whey to form pure, individual dairy protein fractions might allow individuals with special nutritional needs to tailor their diet to improve health. Ion exchange process chromatography was examined for this purpose using selective elution to release separately the proteins bound from whey and produce several protein fractions. Alternatively, bound proteins were released all at once to make a whey protein isolate. Prototype beverages containing these proteins were examined for clarity before and after thermal processing. Beverages containing whey protein isolate were clear at pH 2-7 before heating, but only beverages at pH <or= 3.0 were clear after thermal processing (88 degrees C, 120 s). Beverages at higher pH were made clear after heating by addition of food-grade lauryl sulfate, which prevented aggregation of the denatured proteins formed during thermal processing. Alternatively, thermally processed clear beverages at pH 3-7 were possible using the whey protein glycomacropeptide. Because of the balance between sweetness and acidity, beverages with a pH greater than carbonated soft drinks and juices (pH 2.5-3) might remain palatable using less sugar. Development of high-protein low-carbohydrate beverages might provide health benefits for individuals suffering from diabetes, obesity, and hypercholesterolemia, especially when these beverages contain dairy protein fractions known to be high in essential amino acids and branched-chain amino acids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051860     DOI: 10.1093/jn/134.4.996S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  35 in total

1.  Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.

Authors:  Denise M Ney; Sangita G Murali; Bridget M Stroup; Nivedita Nair; Emily A Sawin; Fran Rohr; Harvey L Levy
Journal:  Mol Genet Metab       Date:  2017-04-06       Impact factor: 4.797

2.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

3.  Dietary whey protein influences plasma satiety-related hormones and plasma amino acids in normal-weight adult women.

Authors:  S M S Chungchunlam; S J Henare; S Ganesh; P J Moughan
Journal:  Eur J Clin Nutr       Date:  2015-01-07       Impact factor: 4.016

4.  Nutritional Management of Phenylketonuria.

Authors:  Erin L Macleod; Denise M Ney
Journal:  Ann Nestle Eng       Date:  2010-06

Review 5.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Authors:  Sandra C van Calcar; Denise M Ney
Journal:  J Acad Nutr Diet       Date:  2012-08       Impact factor: 4.910

6.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

Review 7.  Nutritional management of PKU with glycomacropeptide from cheese whey.

Authors:  D M Ney; S T Gleason; S C van Calcar; E L MacLeod; K L Nelson; M R Etzel; G M Rice; J A Wolff
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

8.  Effect of protein/essential amino acids and resistance training on skeletal muscle hypertrophy: A case for whey protein.

Authors:  Juha J Hulmi; Christopher M Lockwood; Jeffrey R Stout
Journal:  Nutr Metab (Lond)       Date:  2010-06-17       Impact factor: 4.169

9.  Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.

Authors:  Emily A Sawin; Travis J De Wolfe; Busra Aktas; Bridget M Stroup; Sangita G Murali; James L Steele; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

10.  Purification and use of glycomacropeptide for nutritional management of phenylketonuria.

Authors:  Caitlin E Laclair; Denise M Ney; Erin L MacLeod; Mark R Etzel
Journal:  J Food Sci       Date:  2009 May-Jul       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.